UNSPSC 85515911: Dilation of right posterior tibial artery with intraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to dilation of right posterior tibial artery with intraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 047R3DZ

UNSPSC 85515911 Dilation of right posterior tibial artery with intraluminal device, percutaneous approach is a Commodity code that does not align with the state and local procurement activity tagged under it. The recent opportunities show no vascular interventions, angioplasty procedures, or medical devices related to arterial dilation. Instead, the solicitations address occupational health surveillance, disability medical evaluations, pharmacy benefit management, temporary health professional staffing, surgical center-of-excellence networks, and youth detention healthcare services—none of which involve the procedural intervention the code nominally describes.

The mismatch reflects a tagging error rather than active state and local demand for this specific vascular procedure code. Issuing bodies in the recent block include the City of Phoenix Retirement Office (Arizona), the City of Long Beach (California), the Washington State Department of Transportation, Harris County Juvenile Probation Department (Texas), Collier County Board of County Commissioners (Florida), and the County of Santa Clara Health System (California). The work being solicited spans multiple health service domains—occupational medicine surveillance (WSDOT), independent disability medical evaluations (Phoenix), surgical procedure carve-outs for municipal employees (Long Beach), and temporary health professional staffing across ancillary clinical categories (Santa Clara)—but none constitutes procurement of the arterial dilation procedure. This code shows little relevant recent activity for firms pursuing state and local vascular intervention or medical device opportunities.